Posts by tag
recurrence
Sleep & Cancer: Why Rest Matters More Than You Think?
Difficulty sleeping and disturbed sleep patterns are not uncommon among cancer patients, and alleviating these symptoms has always been integral to good cancer care. Now, mounting evidence of the impact that getting enough deep sleep can have on outcomes in…
Supporting mental health helps patients feel better – could it also improve cancer outcomes?
Psychological stress is a known factor in numerous diseases from heart failure to auto-immune conditions. Evidence is now growing that implicates stress as a factor in cancer as well, with higher rates of recurrence and progression found in people experiencing…
Immune resilience: a clue to why some people live longer, have fewer infections, and get less recurrent cancer
Kidney transplant patients with high immune resilience, defined as the capacity to preserve/restore immunocompetence and control inflammation during inflammatory stress, are less likely to develop recurrent skin cancer compared to those with low immune resilience. An international study, published online…
Repurposed drug combination reduces risk of recurrence following surgery for colorectal cancer
Pharmacological suppression of adrenergic and inflammatory signalling using readily available drugs to lower blood pressure and reduce anxiety decreased the risk of post-surgical colorectal cancer (CRC) recurrence. The pilot COMPIT study, published in the European Journal of Surgical Oncology, 6…
Born to be walkers? How to stay healthy in a sedentary world
Humans have been endurance runners and walkers for at least 2 million years. Walking and running are our two main gaits. Whether we are more predisposed for the former or the latter is under debate. Studies carried out in the…
Circulating tumour DNA provides early warning of metastatic breast cancer
In high-risk hormone receptor positive breast cancer circulating tumour DNA (ctDNA) was identified a median of one year before distant metastasis. The study, published in the Journal of Clinical Oncology (4th June, 2022), represents the first prospective investigation of plasma…